DE3447075A1 - Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel - Google Patents
Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittelInfo
- Publication number
- DE3447075A1 DE3447075A1 DE19843447075 DE3447075A DE3447075A1 DE 3447075 A1 DE3447075 A1 DE 3447075A1 DE 19843447075 DE19843447075 DE 19843447075 DE 3447075 A DE3447075 A DE 3447075A DE 3447075 A1 DE3447075 A1 DE 3447075A1
- Authority
- DE
- Germany
- Prior art keywords
- group
- general formula
- radicals
- carbon atoms
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- ALUQMCBDQKDRAK-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1,3-benzothiazole Chemical class C1C=CC=C2SCNC21 ALUQMCBDQKDRAK-UHFFFAOYSA-N 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 title claims description 4
- 239000000543 intermediate Substances 0.000 title abstract description 5
- -1 pyrrolidino, piperidino, hexamethylenimino Chemical group 0.000 claims abstract description 68
- 150000001875 compounds Chemical class 0.000 claims abstract description 65
- 239000002253 acid Substances 0.000 claims abstract description 28
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 28
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 18
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 15
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 13
- 125000003884 phenylalkyl group Chemical group 0.000 claims abstract description 12
- 125000002252 acyl group Chemical group 0.000 claims abstract description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 9
- 239000000460 chlorine Chemical group 0.000 claims abstract description 8
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 8
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 7
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims abstract description 6
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 230000008569 process Effects 0.000 claims abstract description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000001246 bromo group Chemical group Br* 0.000 claims abstract description 3
- 239000011737 fluorine Substances 0.000 claims abstract description 3
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims abstract description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 3
- 150000003254 radicals Chemical class 0.000 claims description 36
- 125000004432 carbon atom Chemical group C* 0.000 claims description 30
- 239000000126 substance Substances 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 15
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 229910052987 metal hydride Inorganic materials 0.000 claims description 7
- 150000004681 metal hydrides Chemical class 0.000 claims description 7
- 230000001681 protective effect Effects 0.000 claims description 7
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 230000010933 acylation Effects 0.000 claims description 4
- 238000005917 acylation reaction Methods 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 230000000269 nucleophilic effect Effects 0.000 claims description 4
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 4
- 239000012279 sodium borohydride Substances 0.000 claims description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 4
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 claims description 3
- YNLWAJULBSGGFC-UHFFFAOYSA-N 6-n,6-n-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(N(C)C)CCC2=C1SC(N)=N2 YNLWAJULBSGGFC-UHFFFAOYSA-N 0.000 claims description 3
- 125000003277 amino group Chemical group 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- GJLUFTKZCBBYMV-UHFFFAOYSA-N carbamimidoylsulfanyl carbamimidothioate Chemical compound NC(=N)SSC(N)=N GJLUFTKZCBBYMV-UHFFFAOYSA-N 0.000 claims description 2
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 2
- 125000004803 chlorobenzyl group Chemical group 0.000 claims description 2
- 238000003776 cleavage reaction Methods 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 230000007017 scission Effects 0.000 claims description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- FASDKYOPVNHBLU-UHFFFAOYSA-N N6-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(NCCC)CCC2=C1SC(N)=N2 FASDKYOPVNHBLU-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000012038 nucleophile Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 210000003169 central nervous system Anatomy 0.000 abstract description 3
- 238000002844 melting Methods 0.000 description 78
- 230000008018 melting Effects 0.000 description 78
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 238000000354 decomposition reaction Methods 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 229960003638 dopamine Drugs 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- HXQHTEYOMJKMJW-UHFFFAOYSA-N 6-n,6-n-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(N(C)C)CCC2=C1SC(N)=N2 HXQHTEYOMJKMJW-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000829 suppository Substances 0.000 description 6
- IMLXLGZJLAOKJN-UHFFFAOYSA-N 4-aminocyclohexan-1-ol Chemical compound NC1CCC(O)CC1 IMLXLGZJLAOKJN-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- NHTGHBARYWONDQ-JTQLQIEISA-N L-α-methyl-Tyrosine Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C=C1 NHTGHBARYWONDQ-JTQLQIEISA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000008298 dragée Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- JGSJAYTWMVKMPF-UHFFFAOYSA-N 2-(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(N=C(S2)N)=C2C1 JGSJAYTWMVKMPF-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- LMBFUMXVHAJSNJ-UHFFFAOYSA-N 4-(dimethylamino)cyclohexan-1-one Chemical compound CN(C)C1CCC(=O)CC1 LMBFUMXVHAJSNJ-UHFFFAOYSA-N 0.000 description 3
- FVWZZFNLICGLMQ-UHFFFAOYSA-N 4-[(4-chlorophenyl)methylamino]cyclohexan-1-ol Chemical compound C1CC(O)CCC1NCC1=CC=C(Cl)C=C1 FVWZZFNLICGLMQ-UHFFFAOYSA-N 0.000 description 3
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 102000015554 Dopamine receptor Human genes 0.000 description 3
- 108050004812 Dopamine receptor Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 229960004502 levodopa Drugs 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- GTLWIYXHOXLEDV-UHFFFAOYSA-N n-(6-acetamido-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)benzamide Chemical compound S1C=2CC(NC(=O)C)CCC=2N=C1NC(=O)C1=CC=CC=C1 GTLWIYXHOXLEDV-UHFFFAOYSA-N 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- YLHCMDNAKVPTIO-UHFFFAOYSA-N 2-(4-hydroxycyclohexyl)isoindole-1,3-dione Chemical compound C1CC(O)CCC1N1C(=O)C2=CC=CC=C2C1=O YLHCMDNAKVPTIO-UHFFFAOYSA-N 0.000 description 2
- PWUJQPNLEZZILN-UHFFFAOYSA-N 2-(4-oxocyclohexyl)isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C1CCC(=O)CC1 PWUJQPNLEZZILN-UHFFFAOYSA-N 0.000 description 2
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 2
- DRRYZHHKWSHHFT-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(N)CCC2=C1SC(N)=N2 DRRYZHHKWSHHFT-UHFFFAOYSA-N 0.000 description 2
- PVBPCZPKXZJHAL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine hydrochloride Chemical compound Cl.C1C(N)CCC2=C1SC(N)=N2 PVBPCZPKXZJHAL-UHFFFAOYSA-N 0.000 description 2
- GIGISQYCOSTTCZ-UHFFFAOYSA-N 4-(azepan-1-yl)cyclohexan-1-ol Chemical compound C1CC(O)CCC1N1CCCCCC1 GIGISQYCOSTTCZ-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- POWFUERMECNPGR-UHFFFAOYSA-N 4-[(4-chlorophenyl)methyl-methylamino]cyclohexan-1-one Chemical compound C1CC(=O)CCC1N(C)CC1=CC=C(Cl)C=C1 POWFUERMECNPGR-UHFFFAOYSA-N 0.000 description 2
- VASZILLAAVFOHH-UHFFFAOYSA-N 4-[(4-chlorophenyl)methylamino]cyclohexan-1-one Chemical compound C1=CC(Cl)=CC=C1CNC1CCC(=O)CC1 VASZILLAAVFOHH-UHFFFAOYSA-N 0.000 description 2
- RKTQEVMZBCBOSB-UHFFFAOYSA-N 4-aminocyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1CCC(O)CC1 RKTQEVMZBCBOSB-UHFFFAOYSA-N 0.000 description 2
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 240000004760 Pimpinella anisum Species 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 2
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 2
- 229940008406 diethyl sulfate Drugs 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- QMNWXHSYPXQFSK-UHFFFAOYSA-N hydron;6-n-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dichloride Chemical compound Cl.Cl.C1C(NCCC)CCC2=C1SC(N)=N2 QMNWXHSYPXQFSK-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- BCPYBDSAYGHITO-UHFFFAOYSA-N n-(2-acetamido-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide Chemical compound C1C(NC(=O)C)CCC2=C1SC(NC(C)=O)=N2 BCPYBDSAYGHITO-UHFFFAOYSA-N 0.000 description 2
- QXKCTWPNUINDQK-UHFFFAOYSA-N n-(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide Chemical compound C1C(NC(=O)C)CCC2=C1SC(N)=N2 QXKCTWPNUINDQK-UHFFFAOYSA-N 0.000 description 2
- XDWSUEPXEWCNIX-UHFFFAOYSA-N n-(2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl)acetamide;hydrobromide Chemical compound Br.C1C(NC(=O)C)CCC2=C1SC(N)=N2 XDWSUEPXEWCNIX-UHFFFAOYSA-N 0.000 description 2
- WZEMYWNHKFIVKE-UHFFFAOYSA-N n-(4-oxocyclohexyl)acetamide Chemical compound CC(=O)NC1CCC(=O)CC1 WZEMYWNHKFIVKE-UHFFFAOYSA-N 0.000 description 2
- UEXQQXFEUULFHJ-UHFFFAOYSA-N n-[2-(methylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound C1CC(NC(C)=O)CC2=C1N=C(NC)S2 UEXQQXFEUULFHJ-UHFFFAOYSA-N 0.000 description 2
- 230000001242 postsynaptic effect Effects 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 230000003518 presynaptic effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229960001462 sodium cyclamate Drugs 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- UQYVXUYSPOIQIH-UHFFFAOYSA-N 1,3-benzothiazole dihydrochloride Chemical compound Cl.Cl.C1=CC=C2SC=NC2=C1 UQYVXUYSPOIQIH-UHFFFAOYSA-N 0.000 description 1
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 1
- SGRHVVLXEBNBDV-UHFFFAOYSA-N 1,6-dibromohexane Chemical compound BrCCCCCCBr SGRHVVLXEBNBDV-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- PXJIHOGDTGXVCO-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C=C(N)C=C2SC(N)NC21 PXJIHOGDTGXVCO-UHFFFAOYSA-N 0.000 description 1
- PFCYJQNMEJAGNA-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1,3-benzothiazole;dihydrochloride Chemical compound Cl.Cl.C1C=CC=C2SCNC21 PFCYJQNMEJAGNA-UHFFFAOYSA-N 0.000 description 1
- RKRSOAKHKAHABO-UHFFFAOYSA-N 2-N,6-N-diethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride Chemical compound Cl.Cl.C1C(NCC)CCC2=C1SC(NCC)=N2 RKRSOAKHKAHABO-UHFFFAOYSA-N 0.000 description 1
- VLQRZSCSJMWMKW-UHFFFAOYSA-N 2-N-benzyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 2-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine tetrahydrobromide Chemical compound Br.Br.NC1CC2=C(N=C(S2)NCCC)CC1.Br.Br.NC1CC2=C(N=C(S2)NCC2=CC=CC=C2)CC1 VLQRZSCSJMWMKW-UHFFFAOYSA-N 0.000 description 1
- CPZHLWWDLNRNEG-UHFFFAOYSA-N 2-n,2-n-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1CC(N)CC2=C1N=C(N(C)C)S2 CPZHLWWDLNRNEG-UHFFFAOYSA-N 0.000 description 1
- LFYWMJZDHWIJLN-UHFFFAOYSA-N 2-n-(2-phenylethyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrobromide Chemical compound Br.Br.S1C=2CC(N)CCC=2N=C1NCCC1=CC=CC=C1 LFYWMJZDHWIJLN-UHFFFAOYSA-N 0.000 description 1
- RABVVSIYWRTIBM-UHFFFAOYSA-N 2-n-benzyl-6-n-ethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.S1C=2CC(NCC)CCC=2N=C1NCC1=CC=CC=C1 RABVVSIYWRTIBM-UHFFFAOYSA-N 0.000 description 1
- PLJJQOXAGLPOHL-UHFFFAOYSA-N 2-n-ethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1CC(N)CC2=C1N=C(NCC)S2 PLJJQOXAGLPOHL-UHFFFAOYSA-N 0.000 description 1
- PJIWXTPUZYLORE-UHFFFAOYSA-N 2-n-methyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;hydrobromide Chemical compound Br.C1CC(N)CC2=C1N=C(NC)S2 PJIWXTPUZYLORE-UHFFFAOYSA-N 0.000 description 1
- CRDLYEPKOVZEJC-UHFFFAOYSA-N 3-(dimethylamino)cyclohexan-1-one Chemical compound CN(C)C1CCCC(=O)C1 CRDLYEPKOVZEJC-UHFFFAOYSA-N 0.000 description 1
- QOXJWHAYYZUAHR-UHFFFAOYSA-N 3-(hydrazinylmethyl)phenol;hydrochloride Chemical compound Cl.NNCC1=CC=CC(O)=C1 QOXJWHAYYZUAHR-UHFFFAOYSA-N 0.000 description 1
- AOOJTVGXMWJONZ-UHFFFAOYSA-N 3-morpholin-4-ylcyclohexan-1-one Chemical compound C1C(=O)CCCC1N1CCOCC1 AOOJTVGXMWJONZ-UHFFFAOYSA-N 0.000 description 1
- KCVOHQHKKGDISI-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrobromide Chemical compound Br.Br.C1C(N)CCC2=C1SC(N)=N2 KCVOHQHKKGDISI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- ANOSNEIXOWYTEL-UHFFFAOYSA-N 4-(azepan-1-yl)cyclohexan-1-one Chemical compound C1CC(=O)CCC1N1CCCCCC1 ANOSNEIXOWYTEL-UHFFFAOYSA-N 0.000 description 1
- PFMXCSVZQNOESL-UHFFFAOYSA-N 4-(diethylamino)cyclohexan-1-ol Chemical compound CCN(CC)C1CCC(O)CC1 PFMXCSVZQNOESL-UHFFFAOYSA-N 0.000 description 1
- LIWZZXVRVDSDBT-UHFFFAOYSA-N 4-(diethylamino)cyclohexan-1-one Chemical compound CCN(CC)C1CCC(=O)CC1 LIWZZXVRVDSDBT-UHFFFAOYSA-N 0.000 description 1
- HWRKEVLDEGZFNL-UHFFFAOYSA-N 4-(propylamino)cyclohexan-1-ol Chemical compound CCCNC1CCC(O)CC1 HWRKEVLDEGZFNL-UHFFFAOYSA-N 0.000 description 1
- KGYWGNKOKDOANR-UHFFFAOYSA-N 4-(propylamino)cyclohexan-1-one Chemical compound CCCNC1CCC(=O)CC1 KGYWGNKOKDOANR-UHFFFAOYSA-N 0.000 description 1
- JNOXGXIJSHUBFQ-UHFFFAOYSA-N 4-[(4-chlorophenyl)methyl-ethylamino]cyclohexan-1-one Chemical compound C1CC(=O)CCC1N(CC)CC1=CC=C(Cl)C=C1 JNOXGXIJSHUBFQ-UHFFFAOYSA-N 0.000 description 1
- GRHJBIBHPAROCS-UHFFFAOYSA-N 4-[(4-chlorophenyl)methyl-methylamino]cyclohexan-1-ol Chemical compound C1CC(O)CCC1N(C)CC1=CC=C(Cl)C=C1 GRHJBIBHPAROCS-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- VHFKXROBNKLENX-UHFFFAOYSA-N 4-piperidin-1-ylcyclohexan-1-ol Chemical compound C1CC(O)CCC1N1CCCCC1 VHFKXROBNKLENX-UHFFFAOYSA-N 0.000 description 1
- ZNDMWZIAZJLETD-UHFFFAOYSA-N 4-piperidin-1-ylcyclohexan-1-one Chemical compound C1CC(=O)CCC1N1CCCCC1 ZNDMWZIAZJLETD-UHFFFAOYSA-N 0.000 description 1
- FVSJBIVLSOXEDU-UHFFFAOYSA-N 4-pyrrolidin-1-ylcyclohexan-1-ol Chemical compound C1CC(O)CCC1N1CCCC1 FVSJBIVLSOXEDU-UHFFFAOYSA-N 0.000 description 1
- RDGIABKZGSKWCC-UHFFFAOYSA-N 4-pyrrolidin-1-ylcyclohexan-1-one Chemical compound C1CC(=O)CCC1N1CCCC1 RDGIABKZGSKWCC-UHFFFAOYSA-N 0.000 description 1
- XVZDYPISSVWGRF-UHFFFAOYSA-N 5-morpholin-4-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;dihydrochloride Chemical compound Cl.Cl.C1CC=2SC(N)=NC=2CC1N1CCOCC1 XVZDYPISSVWGRF-UHFFFAOYSA-N 0.000 description 1
- NSSRSWRXUMNKNQ-UHFFFAOYSA-N 5-n,5-n-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,5-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(N(C)C)CCC2=C1N=C(N)S2 NSSRSWRXUMNKNQ-UHFFFAOYSA-N 0.000 description 1
- ZSLYKPSDSOUNSV-UHFFFAOYSA-N 6-(azepan-1-yl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;dihydrochloride Chemical compound Cl.Cl.C1C=2SC(N)=NC=2CCC1N1CCCCCC1 ZSLYKPSDSOUNSV-UHFFFAOYSA-N 0.000 description 1
- DTIGCFSEOLCPBE-UHFFFAOYSA-N 6-n,6-n-diethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C(N(CC)CC)CCC2=C1SC(N)=N2 DTIGCFSEOLCPBE-UHFFFAOYSA-N 0.000 description 1
- BIOCWOQKSCDJRB-UHFFFAOYSA-N 6-n-(2-methylpropyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NCC(C)C)CCC2=C1SC(N)=N2 BIOCWOQKSCDJRB-UHFFFAOYSA-N 0.000 description 1
- MJWNGTITCBMFDD-UHFFFAOYSA-N 6-n-(2-phenylethyl)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C=2SC(N)=NC=2CCC1NCCC1=CC=CC=C1 MJWNGTITCBMFDD-UHFFFAOYSA-N 0.000 description 1
- JTPWQTUENZLRPW-UHFFFAOYSA-N 6-n-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C=2SC(N)=NC=2CCC1NCC1=CC=CC=C1Cl JTPWQTUENZLRPW-UHFFFAOYSA-N 0.000 description 1
- FMKWREZTAUBXOD-UHFFFAOYSA-N 6-n-[(4-chlorophenyl)methyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1C=2SC(N)=NC=2CCC1NCC1=CC=C(Cl)C=C1 FMKWREZTAUBXOD-UHFFFAOYSA-N 0.000 description 1
- AXHLELYLTFLDPL-UHFFFAOYSA-N 6-n-[(4-chlorophenyl)methyl]-6-n-ethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1CC=2N=C(N)SC=2CC1N(CC)CC1=CC=C(Cl)C=C1 AXHLELYLTFLDPL-UHFFFAOYSA-N 0.000 description 1
- GQZXDESEGFXDMM-UHFFFAOYSA-N 6-n-[(4-chlorophenyl)methyl]-6-n-methyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Chemical compound C1CC=2N=C(N)SC=2CC1N(C)CC1=CC=C(Cl)C=C1 GQZXDESEGFXDMM-UHFFFAOYSA-N 0.000 description 1
- WTXUEEWKMNSIQW-UHFFFAOYSA-N 6-n-butyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NCCCC)CCC2=C1SC(N)=N2 WTXUEEWKMNSIQW-UHFFFAOYSA-N 0.000 description 1
- ZJRMVTIHKLNXCV-UHFFFAOYSA-N 6-n-cyclohexyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C=2SC(N)=NC=2CCC1NC1CCCCC1 ZJRMVTIHKLNXCV-UHFFFAOYSA-N 0.000 description 1
- KAOGOKXXJGHVCH-UHFFFAOYSA-N 6-n-cyclopentyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O.C1C=2SC(N)=NC=2CCC1NC1CCCC1 KAOGOKXXJGHVCH-UHFFFAOYSA-N 0.000 description 1
- RTIOZZPBYOWLAO-UHFFFAOYSA-N 6-n-ethyl-2-n,2-n-dimethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;oxalic acid;hydrate Chemical compound O.OC(=O)C(O)=O.C1C(NCC)CCC2=C1SC(N(C)C)=N2 RTIOZZPBYOWLAO-UHFFFAOYSA-N 0.000 description 1
- JBRBZELYQSMOHA-UHFFFAOYSA-N 6-n-ethyl-2-n-methyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NCC)CCC2=C1SC(NC)=N2 JBRBZELYQSMOHA-UHFFFAOYSA-N 0.000 description 1
- YREXSOYEXXWDDG-UHFFFAOYSA-N 6-n-ethyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NCC)CCC2=C1SC(N)=N2 YREXSOYEXXWDDG-UHFFFAOYSA-N 0.000 description 1
- FVHGZXOUSYJFRC-UHFFFAOYSA-N 6-n-hexyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NCCCCCC)CCC2=C1SC(N)=N2 FVHGZXOUSYJFRC-UHFFFAOYSA-N 0.000 description 1
- QHUIBGZSFSBZAU-UHFFFAOYSA-N 6-n-methyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrobromide Chemical compound Br.Br.C1C(NC)CCC2=C1SC(N)=N2 QHUIBGZSFSBZAU-UHFFFAOYSA-N 0.000 description 1
- VSWQMWPSAXJLGN-UHFFFAOYSA-N 6-n-prop-2-ynyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1CC(NCC#C)CC2=C1N=C(N)S2 VSWQMWPSAXJLGN-UHFFFAOYSA-N 0.000 description 1
- YZHQPVDCNALEGC-UHFFFAOYSA-N 6-n-propan-2-yl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride Chemical compound Cl.Cl.C1C(NC(C)C)CCC2=C1SC(N)=N2 YZHQPVDCNALEGC-UHFFFAOYSA-N 0.000 description 1
- DUILSBNKJQJKJI-UHFFFAOYSA-N 6-piperidin-1-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;dihydrochloride Chemical compound Cl.Cl.C1C=2SC(N)=NC=2CCC1N1CCCCC1 DUILSBNKJQJKJI-UHFFFAOYSA-N 0.000 description 1
- LDZIKTGDUJXEIJ-UHFFFAOYSA-N 6-pyrrolidin-1-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine Chemical compound C1C=2SC(N)=NC=2CCC1N1CCCC1 LDZIKTGDUJXEIJ-UHFFFAOYSA-N 0.000 description 1
- QXAPJYLGMIAHKS-UHFFFAOYSA-N 6-pyrrolidin-1-yl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;dihydrochloride Chemical group Cl.Cl.C1C=2SC(N)=NC=2CCC1N1CCCC1 QXAPJYLGMIAHKS-UHFFFAOYSA-N 0.000 description 1
- 102000007527 Autoreceptors Human genes 0.000 description 1
- 108010071131 Autoreceptors Proteins 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- NCAUQPMRMQOOQA-UHFFFAOYSA-N Cl.Cl.C(C)NC1CC2=C(N=C(S2)NCCC2=CC=CC=C2)CC1 Chemical compound Cl.Cl.C(C)NC1CC2=C(N=C(S2)NCCC2=CC=CC=C2)CC1 NCAUQPMRMQOOQA-UHFFFAOYSA-N 0.000 description 1
- DIWVBIXQCNRCFE-UHFFFAOYSA-N DL-alpha-Methoxyphenylacetic acid Chemical compound COC(C(O)=O)C1=CC=CC=C1 DIWVBIXQCNRCFE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- UDZVNVWFYMBJQW-UHFFFAOYSA-N NC=1SC2=C(N1)CCC(C2)NCCCCC Chemical compound NC=1SC2=C(N1)CCC(C2)NCCCCC UDZVNVWFYMBJQW-UHFFFAOYSA-N 0.000 description 1
- CCKJKELTXVOQBO-UHFFFAOYSA-N O.Cl.Cl.C1C(N(CCC)CCC)CCC2=C1SC(N)=N2 Chemical compound O.Cl.Cl.C1C(N(CCC)CCC)CCC2=C1SC(N)=N2 CCKJKELTXVOQBO-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 206010034010 Parkinsonism Diseases 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 1
- HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 1
- HTKFORQRBXIQHD-UHFFFAOYSA-N allylthiourea Chemical compound NC(=S)NCC=C HTKFORQRBXIQHD-UHFFFAOYSA-N 0.000 description 1
- 229960001748 allylthiourea Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- XMMQCGZNDYCCQF-UHFFFAOYSA-N carbamimidoylsulfanyl carbamimidothioate;dihydrobromide Chemical compound [Br-].[Br-].[NH3+]C(=N)SSC([NH3+])=N XMMQCGZNDYCCQF-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- NGPGDYLVALNKEG-OLXYHTOASA-N diammonium L-tartrate Chemical compound [NH4+].[NH4+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O NGPGDYLVALNKEG-OLXYHTOASA-N 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- HBOHTPMGARQGJZ-UHFFFAOYSA-N n-(6-acetamido-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)propanamide Chemical compound C1CC(NC(C)=O)CC2=C1N=C(NC(=O)CC)S2 HBOHTPMGARQGJZ-UHFFFAOYSA-N 0.000 description 1
- USVAYKVHLLYZBC-UHFFFAOYSA-N n-[2-(2-phenylethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound S1C=2CC(NC(=O)C)CCC=2N=C1NCCC1=CC=CC=C1 USVAYKVHLLYZBC-UHFFFAOYSA-N 0.000 description 1
- KHGYHNYVZMYHPI-UHFFFAOYSA-N n-[2-(benzylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound S1C=2CC(NC(=O)C)CCC=2N=C1NCC1=CC=CC=C1 KHGYHNYVZMYHPI-UHFFFAOYSA-N 0.000 description 1
- BTMFIPSQSLSTBF-UHFFFAOYSA-N n-[2-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound C1CC(NC(C)=O)CC2=C1N=C(N(C)C)S2 BTMFIPSQSLSTBF-UHFFFAOYSA-N 0.000 description 1
- JBRICXJYBMNOHB-UHFFFAOYSA-N n-[2-(ethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound C1CC(NC(C)=O)CC2=C1N=C(NCC)S2 JBRICXJYBMNOHB-UHFFFAOYSA-N 0.000 description 1
- PNMCRBIZBUGPTD-UHFFFAOYSA-N n-[2-(propylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]acetamide Chemical compound C1CC(NC(C)=O)CC2=C1N=C(NCCC)S2 PNMCRBIZBUGPTD-UHFFFAOYSA-N 0.000 description 1
- CMVOQILWMOWEIH-UHFFFAOYSA-N n-[6-(dimethylamino)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl]benzamide;dihydrochloride Chemical compound Cl.Cl.S1C=2CC(N(C)C)CCC=2N=C1NC(=O)C1=CC=CC=C1 CMVOQILWMOWEIH-UHFFFAOYSA-N 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007530 organic bases Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Priority Applications (36)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843447075 DE3447075A1 (de) | 1984-12-22 | 1984-12-22 | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
| EP85116016A EP0186087B1 (de) | 1984-12-22 | 1985-12-16 | Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel |
| AT85116016T ATE45735T1 (de) | 1984-12-22 | 1985-12-16 | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel. |
| DE8585116016T DE3572485D1 (en) | 1984-12-22 | 1985-12-16 | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| DK590285A DK168862B1 (da) | 1984-12-22 | 1985-12-18 | Tetrahydrobenzthiazoler, lægemidler som indeholder dem, fremgangsmåde til fremstilling af disse lægemidler samt fremgangsmåde til fremstilling af tetrahydrobenzthiazolerne |
| US06/810,947 US4731374A (en) | 1984-12-22 | 1985-12-19 | Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals |
| JP60287601A JPS61155377A (ja) | 1984-12-22 | 1985-12-20 | テトラヒドロ‐ベンズチアゾール化合物およびその製造方法 |
| HU854935A HU193618B (en) | 1984-12-22 | 1985-12-20 | Process for producing tetra-hydrobenz-thiazoles |
| IL77415A IL77415A (en) | 1984-12-22 | 1985-12-20 | Diamino-tetrahydrobenzthiazoles,their preparation and pharmaceutical compositions containing them |
| PT81735A PT81735B (pt) | 1984-12-22 | 1985-12-20 | Processo para a preparacao de tetrahidro--benzotiazois e de composicoes farmaceuticas que os contem |
| FI855102A FI81787C (fi) | 1984-12-22 | 1985-12-20 | Foerfarande foer framstaellning av farmakologiskt vaerdefull tetrahydrobenztiatsol. |
| ES550235A ES8702787A1 (es) | 1984-12-22 | 1985-12-20 | Procedimiento para preparar nuevos tetrahidro-benzotiazoles. |
| AU51544/85A AU583874B2 (en) | 1984-12-22 | 1985-12-20 | Tetrahydrobenzthiazoles |
| CA000498237A CA1263653A (en) | 1984-12-22 | 1985-12-20 | Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals |
| DD85284921A DD242230A5 (de) | 1984-12-22 | 1985-12-20 | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
| IE327085A IE58863B1 (en) | 1984-12-22 | 1985-12-20 | Tetrahydro-benzthiazoles |
| NO855195A NO165070C (no) | 1984-12-22 | 1985-12-20 | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenztiazoler. |
| PH33232A PH24533A (en) | 1984-12-22 | 1985-12-20 | Tetrahydro-benzthiazoles,the preparation thereof and their use as intermediate products or as pharmaceuticals |
| GR853126A GR853126B (enrdf_load_stackoverflow) | 1984-12-22 | 1985-12-20 | |
| NZ214661A NZ214661A (en) | 1984-12-22 | 1985-12-20 | Tetrahydro benzothiazole derivatives and pharmaceutical compositions |
| ZA859731A ZA859731B (en) | 1984-12-22 | 1985-12-20 | Pharmaceutical compositions containing tetrahydrobenzthiazoles |
| KR1019850009688A KR930009791B1 (ko) | 1984-12-22 | 1985-12-21 | 테트라하이드로-벤즈티아졸의제조방법 |
| ES556874D ES8707514B9 (es) | 1984-12-22 | 1986-07-03 | Procedimiento para preparar nuevos tetrahidro-benzotiazoles. |
| ES556875A ES8707515A1 (es) | 1984-12-22 | 1986-07-03 | Procedimiento para preparar nuevos tetrahidro-benzotiazoles |
| ES556873A ES8707513A1 (es) | 1984-12-22 | 1986-07-03 | Procedimiento para preparar nuevos tetrahidro-benzotiazoles. |
| ES556874A ES8707514A1 (es) | 1984-12-22 | 1986-07-03 | Procedimiento para preparar nuevos tetrahidro-benzotiazoles. |
| US07/124,197 US4843086A (en) | 1984-12-22 | 1987-11-23 | Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals |
| US07/256,671 US4886812A (en) | 1984-12-22 | 1988-10-12 | Tetrahydro-benzthiazoles, the preparation thereof and their use as intermediate products or as pharmaceuticals |
| CS914099A CS409991A3 (en) | 1984-12-22 | 1991-12-27 | Tetrahydrobenzothiazole derivatives, process of their preparation andpharmaceutical compositions containing them |
| MX9202792A MX9202792A (es) | 1984-12-22 | 1992-06-11 | Tetrahidro-benzotiazoles y procedimiento para su preparacion. |
| SG824/92A SG82492G (en) | 1984-12-22 | 1992-08-18 | Tetrahydro-benzothiazoles,their production and their use as intermediates or drugs |
| HK786/92A HK78692A (en) | 1984-12-22 | 1992-10-15 | Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs |
| BG098405A BG62023B2 (bg) | 1984-12-22 | 1994-01-24 | Тетрахидробензтиазоли,метод за получаването и приложението им като междинни продукти или като лекарствени средства |
| BR1100678-1A BR1100678A (pt) | 1984-12-22 | 1997-05-08 | Tetrahidro-benzoatiazol, sua preparação e seu uso como produto intermediário ou como medicamento |
| NL980002C NL980002I2 (nl) | 1984-12-22 | 1998-01-09 | Tetrahydro-benzthiazolen, hun bereiding en hun toepassing als tussenprodukten of als geneesmiddel. |
| LU90208C LU90208I2 (fr) | 1984-12-22 | 1998-01-30 | Pramipexole et ses sels dichlorhydrate monohydraté de pramipexole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843447075 DE3447075A1 (de) | 1984-12-22 | 1984-12-22 | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3447075A1 true DE3447075A1 (de) | 1986-07-03 |
Family
ID=6253655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19843447075 Withdrawn DE3447075A1 (de) | 1984-12-22 | 1984-12-22 | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS61155377A (enrdf_load_stackoverflow) |
| BR (1) | BR1100678A (enrdf_load_stackoverflow) |
| DD (1) | DD242230A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3447075A1 (enrdf_load_stackoverflow) |
| ZA (1) | ZA859731B (enrdf_load_stackoverflow) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3620813A1 (de) * | 1986-06-21 | 1987-12-23 | Boehringer Ingelheim Kg | Neue tetrahydro-benzothiazole, ihre herstellung und verwendung |
| US5650420A (en) * | 1994-12-15 | 1997-07-22 | Pharmacia & Upjohn Company | Pramipexole as a neuroprotective agent |
| SE9802360D0 (sv) * | 1998-07-01 | 1998-07-01 | Wikstroem Hakan Vilhelm | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins ((basic)-N-substituted and (basic)-N,N-disubstituted derivatives of 2,6-diamino-thiazolo(4,5-f)indan and 2,7-di-amino-thiazolo(4,5-g)tetralin |
| US6277875B1 (en) * | 2000-07-17 | 2001-08-21 | Andrew J. Holman | Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
| PL374310A1 (en) * | 2001-12-11 | 2005-10-03 | University Of Virginia Patent Foundation | Use of pramipexole to treat amyotrophic lateral sclerosis |
| US20050226926A1 (en) * | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
| AR040680A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Composicion de tabletas de liberacion sostenida |
| GB2394951A (en) * | 2002-11-04 | 2004-05-12 | Cipla Ltd | One pot synthesis of 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole |
| DE102004006808A1 (de) * | 2004-02-11 | 2005-09-01 | Grünenthal GmbH | Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen |
| EP2289885A1 (en) * | 2004-03-19 | 2011-03-02 | Dipharma Francis S.r.l. | Intermediates for the preparation of pramipexole |
| ES2245604B1 (es) * | 2004-06-25 | 2006-12-01 | Ragactives, S. L. | Procedimiento para la obtencion de 2-amino-6-alquil-amino-4,5,6,7-tetrahidrobenzotiazoles. |
| ES2264378B1 (es) * | 2005-05-09 | 2007-11-01 | Ragactives, S.L. | Procedimiento para la resolucion de 2-amino-6propilamino-4,5,6,7-tetrahidrobenzotiazol y compuestos intermedios. |
| JP2010521496A (ja) * | 2007-03-14 | 2010-06-24 | ノップ ニューロサイエンシーズ、インク． | キラル精製置換ベンゾチアゾールジアミンの合成 |
| WO2008140051A1 (ja) | 2007-05-11 | 2008-11-20 | Santen Pharmaceutical Co., Ltd. | 非麦角系の選択的ｄ２受容体アゴニストを有効成分として含有する後眼部疾患の予防又は治療剤 |
| CN102186350A (zh) | 2008-08-19 | 2011-09-14 | 诺普神经科学股份有限公司 | 使用(r)-普拉克索的组合物与方法 |
| US9512096B2 (en) | 2011-12-22 | 2016-12-06 | Knopp Biosciences, LLP | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
| US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
| AU2014306683B2 (en) | 2013-08-13 | 2017-10-12 | Knopp Biosciences Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
| AU2014306597B2 (en) | 2013-08-13 | 2018-05-17 | Knopp Biosciences Llc | Compositions and methods for treating chronic urticaria |
-
1984
- 1984-12-22 DE DE19843447075 patent/DE3447075A1/de not_active Withdrawn
-
1985
- 1985-12-20 ZA ZA859731A patent/ZA859731B/xx unknown
- 1985-12-20 JP JP60287601A patent/JPS61155377A/ja active Granted
- 1985-12-20 DD DD85284921A patent/DD242230A5/de not_active IP Right Cessation
-
1997
- 1997-05-08 BR BR1100678-1A patent/BR1100678A/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0572907B2 (enrdf_load_stackoverflow) | 1993-10-13 |
| JPS61155377A (ja) | 1986-07-15 |
| ZA859731B (en) | 1987-08-26 |
| DD242230A5 (de) | 1987-01-21 |
| BR1100678A (pt) | 1999-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0186087B1 (de) | Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel | |
| DE3447075A1 (de) | Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel | |
| DE69109871T2 (de) | Pyridin- und pyridin-n-oxid-derivate von diarylmethyl- piperidinen oder piperazinen, deren zusammensetzungen und anwendung. | |
| DE69013836T2 (de) | Benzimidazolverbindungen und deren Anwendung. | |
| CH650782A5 (de) | Carbostyrilverbindungen, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. | |
| EP0314154A2 (de) | Tetrahydro-furo- und -thieno[2,3-c]pyridine, ihre Verwendung als Arzneimittel und Verfahren zu ihrer Herstellung | |
| AT392966B (de) | Verfahren zur herstellung von neuen pyrimidin verbindungen und deren saeureadditionssalzen | |
| DE2429253A1 (de) | Phenylalkanolamine | |
| DE69530988T2 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| EP0271013B1 (de) | Basisch substituierte Phenylacetonitrile, ihre Herstellung und diese enthaltende Arzneimittel | |
| EP1176144B1 (de) | Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten | |
| DE3703435A1 (de) | Neue thiazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
| EP0409048B1 (de) | Aminoalkylsubstituierte 2-Aminothiazole und diese enthaltende therapeutische Mittel | |
| DE3529994A1 (de) | Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung | |
| DE69310904T2 (de) | Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung | |
| DE3442860A1 (de) | 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3- on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| EP0749970B1 (de) | Benzisothiazolyl-substituierte Aminomethylchromane | |
| EP0231003B1 (de) | Basisch substituierte Phenylacetonitrile, ihre Herstellung und diese enthaltende Arzneimittel | |
| EP0307814A2 (de) | Tetracyclische Chinazolinderivate, Herstellung und Verwendung | |
| DE69533214T2 (de) | 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme | |
| DE4019080A1 (de) | Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel | |
| DD202566A5 (de) | Verfahren zur herstellung von 1-phenylindazol-3-on-verbindungen | |
| EP0109636B1 (de) | Benzazepinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel | |
| WO1992022539A1 (de) | Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung | |
| EP0000693A1 (de) | Aminophenoxymethyl-2-morpholinderivate, ihre Herstellung und sie enthaltende Arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |